Your browser doesn't support javascript.
loading
MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms.
Fernández-Garnacho, Elena María; Nadeu, Ferran; Martín, Silvia; Mozas, Pablo; Rivero, Andrea; Delgado, Julio; Giné, Eva; López-Guillermo, Armando; Duran-Ferrer, Martí; Salaverria, Itziar; López, Cristina; Beà, Sílvia; Demajo, Santiago; Jares, Pedro; Puente, Xose S; Martín-Subero, José Ignacio; Campo, Elías; Hernández, Lluís.
Affiliation
  • Fernández-Garnacho EM; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.
  • Nadeu F; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.
  • Martín S; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Mozas P; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.
  • Rivero A; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.
  • Delgado J; Hospital Clínic of Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Giné E; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.
  • López-Guillermo A; Hospital Clínic of Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Duran-Ferrer M; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.
  • Salaverria I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • López C; Hospital Clínic of Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Beà S; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.
  • Demajo S; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Jares P; Hospital Clínic of Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Puente XS; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.
  • Martín-Subero JI; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Campo E; Hospital Clínic of Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Hernández L; Lymphoid Neoplasm Program, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Centre Esther Koplowitz (CEK), Rosselló 153, 08036, Barcelona, Spain.
Sci Rep ; 13(1): 16839, 2023 10 06.
Article in En | MEDLINE | ID: mdl-37803049
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Lymphoma, Follicular / RNA, Long Noncoding Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Lymphoma, Follicular / RNA, Long Noncoding Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article Affiliation country: Spain